The global antibiotics market size is expected to reach USD 74.87 Billion in 2028 at a CAGR of 3.9% during the forecast period, according to latest report by Reports and Data. Increasing prevalence of infectious and bacterial diseases, rising investments to accelerate development of novel antibiotic therapies for infectious diseases, and growing number of RD projects to discover and develop new antibiotics are key factors expected to drive market revenue growth over the forecast period. In addition, antibiotics are commonly used in the production of bacterial and viral vaccines to prevent contamination, which is another key factor expected to support revenue growth of the market.
Antibiotics are widely used in healthcare industry to treat and prevent bacterial and infectious diseases. Bactericidal antibiotics kill bacteria while bacteriostatic antibiotics prevent differentiation and growth of bacteria. Antibiotics are powerful drugs and drug-target interaction and effects of these drugs are well characterized. Over the recent past, various antibiotics are being used for therapeutic purposes and other industries such as animal husbandry and agriculture. Antibiotics are either cytotoxic or cytostatic to microorganisms and allows defense mechanism of the body to eliminate bacteria. These drugs act by inhibiting synthesis of a bacterial cell, synthesis or proteins, DNA, RNA, or other specific actions. Increasing demand for antibiotics across various sectors is leading to development and use of off-label drugs. Rising focus on modification of existing antibiotics to fight emerging resistance of pathogens is another major factor expected to boost revenue growth of the global antibiotics market.
Antibiotics are widely available as over-the-counter drugs and can be bought without any prescription and this is another factor expected to fuel market revenue growth. These drugs have also been used in agricultural animal production as therapeutics to treat disease and prophylactically and to improve growth rate and feed conversion efficiency. Besides treating infectious diseases, antibiotics have made several medical procedures such as cancer treatment, organ transplant, and open heart surgery possible. However, increasing incidence of antibiotic resistance and high costs associated with clinical trials and drug approvals are some key factors that could hamper market revenue growth to a certain extent over the forecast period.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Some key highlights of the report:
- Cell wall inhibitors segment is expected to account for largest revenue share over the forecast period attributable to increasing use of cell wall biosynthesis inhibiting antibiotics to treat drug resistant pathogens and rising focus on inhibition of cell wall synthesis for development of new antibiotics.
- Fluoroquinolones segment is expected to register robust revenue CAGR over the forecast period owing to recent advancements in fluoroquinolones to enhance antimicrobial and pharmacokinetic profiles, rising number of clinical trials to expand application scope of these antibiotics, and growing effectiveness of fluoroquinolones in vitro against gram positive pathogens.
- Oral segment is expected to account for significantly large revenue share over the forecast period attributable to increasing preference for oral antibiotic therapy, numerous advantages of oral administration over intravenous administration, and rising cost-effectiveness of oral administration.
- Hospital pharmacies segment is expected to register considerably high revenue growth rate over the forecast period owing to increasing availability of broad spectrum antibiotics in hospital pharmacies, rising hospital admissions due to bacterial and infectious diseases, and implementation of stringent policies to streamline antibiotic use in hospitals.
- North America is expected to account for largest revenue share between 2021 and 2028 owing to increasing prevalence of infectious diseases, growing investments to accelerate development of novel therapeutics, growing number of clinical trials, and presence of various key players in countries in the region.
- Major companies profiled in the market report include Bristol-Myers Squibb Co., AstraZeneca plc, The Menarini Group, GlaxoSmithKline plc, Bayer HealthCare AG, Eli Lilly and Company, Merck Co., Inc., Johnson Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd., and Sanofi.
Key Players covered in this report are
The global gene expression market is slightly fragmented with presence of several players operating on a global and regional scale. Key players are engaged in product development and strategic alliances to cater to growing global demand and gain a robust footing in the market. Major companies profiled in the market include Bristol-Myers Squibb Co., AstraZeneca Plc, The Menarini Group, GlaxoSmithKline plc, Bayer HealthCare AG, Eli Lilly and Company, Merck Co., Inc., Johnson Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd., and Sanofi.
Type Outlook (Revenue, USD Billion; 2018-2028)
- Protein
- DNA
- RNA
- Cell Wall Synthesis Inhibitors
- Mycolic Acid Inhibitors
Product Outlook (Revenue, USD Billion; 2018-2028)
- Carbapenems
- Penicillin
- Fluoroquinolones
- Macrolides
- Others
Administration Route Outlook (Revenue, USD Billion; 2018-2028)
- Oral
- Topical
- Sublingual
- Inhalation
- Others
End Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Major Points covered in this report are as below:
The Antibiotics Market industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
The Antibiotics Market Market report provides key statistics on the market status of the Antibiotics Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1377
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
